Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2011-04-05
2011-04-05
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C600S436000, C548S250000
Reexamination Certificate
active
07919071
ABSTRACT:
The present invention relates to a contrast agent of Formula I V-L-Z Formula I where V is a non-peptidic vector having affinity for the Angiotensin II receptor, L is a bond, a spacer or a linker moiety and Z represents a moiety detectable in an in vivo imaging procedure of a human or animal body.
REFERENCES:
patent: 5688487 (1997-11-01), Linder et al.
patent: 6264914 (2001-07-01), Klaveness et al.
patent: 7052672 (2006-05-01), Forster et al.
patent: 9165378 (1997-06-01), None
patent: 9818496 (1998-05-01), None
patent: 0177145 (2001-10-01), None
patent: 0192283 (2001-12-01), None
patent: 02070018 (2002-09-01), None
patent: 03006070 (2003-01-01), None
patent: 03006491 (2003-01-01), None
International Search Report for PCT/NO2004/000002 dated Jul. 2004.
International Preliminary Examination Report dated Mar. 2005.
Archer Colin M.
Engell Torgrim
Solbakken Magne
Wadsworth Harry John
GE Healthcare AS
Hartley Michael G
Schlientz Leah
LandOfFree
Contrast agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Contrast agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contrast agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2650803